Advertisement
Advertisement
PRLD
Prelude Therapeutics Incorporated
4.30
USDSponsored
+0.03
+0.73%
Jun 25, 11:17 UTC -4
Open
PRLD Earnings Reports
Positive Surprise Ratio
PRLD beat 16 of 23 last estimates.
70%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.24
Implied change from Q1 26 (Revenue/ EPS)
-100.00%
/+84.62%
Implied change from Q2 25 (Revenue/ EPS)
--
/-41.46%
Prelude Therapeutics Incorporated earnings per share and revenue
On May 12, 2026, PRLD reported earnings of -0.13 USD per share (EPS) for Q1 26, beating the estimate of -0.25 USD, resulting in a 48.68% surprise. Revenue reached 4.58 million, compared to an expected --, with a 0.00% difference. The market reacted with a -3.33% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an increase of 84.62% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
What were Prelude Therapeutics Incorporated's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Prelude Therapeutics Incorporated reported EPS of -$0.13, beating estimates by 48.68%, and revenue of $4.58M, 0% as expectations.
How did the market react to Prelude Therapeutics Incorporated's Q1 2026 earnings?
The stock price moved down -3.33%, changed from $4.80 before the earnings release to $4.64 the day after.
When is Prelude Therapeutics Incorporated expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Prelude Therapeutics Incorporated's next earnings report?
Based on 5
analysts, Prelude Therapeutics Incorporated is expected to report EPS of -$0.24 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement